A phase II trial of an experimental drug that made headlines when it left human volunteers fighting for their lives is about to begin in Russia — as a potential treatment for rheumatoid arthritis. The drug, then known as TGN1412, had caused six male volunteers in London to experience a ‘cytokine storm’ with devastating consequences. Fortunately ...
‘Chilling’ experimental drug returns as potential RA treatment
By Nicola Garrett
6 Apr 2015